Insulin Infusion Pumps Market Research Report, Share, and Forecast to 2025Posted by rekha on November 12th, 2019 “The Insulin Infusion Pumps Market is increasing at prominent growth rate over the forecast period 2019-2025 to reach US$ 8,923.5 Mn by 2025, due to surge in the prevalence of diabetes in various countries across the globe” Precision Business Insights (PBI) in its report titled “Insulin Infusion Pumps Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. The global insulin infusion pumps market projected to reach US$ 8,923.5 Mn by 2025. The insulin infusion pumps market is growing at significant growth rate over the forecast years owing to burgeoning the incidence of diabetes across the globe. For instance, according to International Diabetes Foundation 2017, approximately 425 Mn adults were living with diabetes and expected to reach 629 Mn by 2045. Additionally, development of technologically advanced insulin infusion pumps, surge in disposable income, increase in the adoption of home-based insulin therapies, and favorable reimbursement policies are expected to boost the insulin infusion pumps market. However, high cost of advanced insulin infusion pumps, less acceptance of devices in underdeveloped economies, stringent regulatory guidelines, and product recalls are impede the insulin infusion pumps market. For instance, in June 2019, Medtronic recalled two of its MiniMed insulin pump products due to potential cybersecurity risks. Diabetes care devices market segmented on the basis of product type, application, end user, and region. Request for Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=17062 Blood Glucose Monitoring Devices Segment Expected to Dominate the Market Based on product type, the insulin infusion pumps market is segmented into traditional infusion pump, disposable infusion pump, and smart pump. Among all the products traditional infusion pumps dominated the market in 2018 and is expected to grow at significant CAGR over the forecast period owing to launch of technologically advanced devices, easy to operate, and cost effectiveness of the products. Moreover, smart pump market growing at highest CAGR over the forecast years owing to development of newer devices by the market players. For instance, in August 2018, Roche received EU approval for its Accu-Chek Solo insulin patch pump and wireless touchscreen handheld device to launch in Europe. North America Accounts for Major Revenue Share for Insulin Infusion Pumps Market Precision Business Insights (PBI), insulin infusion pumps market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among the all regions, North America accounted for largest share in global insulin infusion pumps market and the market is projected to surge at significant growth rate over the forecast years owing to favorable reimbursement guidelines, increase in the incidence of diabetes in USA and Canada, and presence of huge number of market players in the region. For instance, according to CDC 2015, approximately 30 Mn Americans have diabetes and another 84 Mn have prediabetes that may leads to type 2 diabetes within 5 years if they are not treated. In addition, Europe insulin infusion pumps market creates lucrative opportunities over the forecast years owing to adoption of innovative devices and frequent product approval for insulin infusion pumps in the region. Strategic Alliances and Launch of Newer Products in Insulin Infusion Pumps Market
Key player’s profiles in the report are Abbott Laboratories, Tandem Diabetes Care, Inc., Novo Nordisk A/S, Ypsomed, Medtronic plc, Becton-Dickinson and Company, Eli Lilly and Company, Cellnovo Group, F. Hoffmann La Roche Ltd., B. Braun Melsungen AG, and Insulet Corporation Detailed Segmentation By Product Type o Traditional Insulin Infusion Pumps o Disposable Insulin Infusion Pumps o Smart Pump By Application o Type 1 Diabetes o Type 2 Diabetes By End User o Hospitals and Clinics o Home Care o Laboratories Geography o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/global-insulin-infusion-pumps-market/ Like it? Share it! More by this author |